Progenics Pharma (PGNX) Reports In-Line Q2 Loss of $0.08
Tweet Send to a Friend
Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) reports a Q2 loss of $0.08, in-line ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
